Home » Topics » BioWorld Science

BioWorld Science
RSS

PEG-rhSOD advancing in preclinical phase

April 5, 1996

Spartaject busulfan to enter phase I

April 5, 1996

ImmuCell arranges for clinical evaluation of CryptoGAM

April 5, 1996

DuPont Merck research into protease inhibitors

April 5, 1996

New data, new approvals for DaunoXome

April 5, 1996

Virend entering phase III

April 5, 1996

New protease inhibitors from BMS

April 5, 1996

Nabi foresees phase I/II trials on CMV NeutraGAM

April 5, 1996

Lidakol formulations receive patent protection

April 5, 1996

Pfizer, Microcide to codevelop antibacterial drugs

April 5, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...